These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 28489577)
1. Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease. Golan T; Stossel C; Schvimer M; Atias D; Halperin S; Buzhor E; Raitses-Gurevich M; Cohen K; Pri-Chen S; Wilson J; Denroche RE; Lungu I; Bartlett JMS; Mbabaali F; Yarden Y; Nataraj NB; Gallinger S; Berger R Oncotarget; 2017 Jun; 8(25):40778-40790. PubMed ID: 28489577 [TBL] [Abstract][Full Text] [Related]
2. Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression. Xie T; Musteanu M; Lopez-Casas PP; Shields DJ; Olson P; Rejto PA; Hidalgo M PLoS One; 2015; 10(11):e0142631. PubMed ID: 26555578 [TBL] [Abstract][Full Text] [Related]
3. Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites. Allaway RJ; Fischer DA; de Abreu FB; Gardner TB; Gordon SR; Barth RJ; Colacchio TA; Wood M; Kacsoh BZ; Bouley SJ; Cui J; Hamilton J; Choi JA; Lange JT; Peterson JD; Padmanabhan V; Tomlinson CR; Tsongalis GJ; Suriawinata AA; Greene CS; Sanchez Y; Smith KD Oncotarget; 2016 Mar; 7(13):17087-102. PubMed ID: 26934555 [TBL] [Abstract][Full Text] [Related]
4. Patient-derived xenograft models of BRCA-associated pancreatic cancers. Golan T; Atias D; Stossel C; Raitses-Gurevich M Adv Drug Deliv Rev; 2021 Apr; 171():257-265. PubMed ID: 33617901 [TBL] [Abstract][Full Text] [Related]
5. Generation and application of patient-derived xenograft models in pancreatic cancer research. Wang CF; Shi XJ Chin Med J (Engl); 2019 Nov; 132(22):2729-2736. PubMed ID: 31725451 [TBL] [Abstract][Full Text] [Related]
6. Ascites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine. Golan T; Atias D; Barshack I; Avivi C; Goldstein RS; Berger R Br J Cancer; 2014 Apr; 110(9):2269-76. PubMed ID: 24667644 [TBL] [Abstract][Full Text] [Related]
7. Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. Magouliotis DE; Lafazanis K; Koutsougianni F; Sakellaridis N; Ioannou M; Zacharoulis D; Dimas K In Vivo; 2022; 36(3):1114-1119. PubMed ID: 35478141 [TBL] [Abstract][Full Text] [Related]
8. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma. Tanaka R; Kageyama K; Kimura K; Eguchi S; Tauchi J; Shinkawa H; Ohira GO; Yamazoe S; Yamamoto A; Tanaka S; Amano R; Tanaka H; Yashiro M; Kubo S; Ohira M Anticancer Res; 2020 May; 40(5):2637-2644. PubMed ID: 32366408 [TBL] [Abstract][Full Text] [Related]
9. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression. Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173 [TBL] [Abstract][Full Text] [Related]
10. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874 [TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of human pancreatic adenocarcinoma cell line in tissue culture and the nude mouse. Kong D; Nishino N; Shibusawa M; Kusano M Tissue Cell; 2007 Aug; 39(4):217-23. PubMed ID: 17560620 [TBL] [Abstract][Full Text] [Related]
12. Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development. Nelson SR; Zhang C; Roche S; O'Neill F; Swan N; Luo Y; Larkin A; Crown J; Walsh N Sci Rep; 2020 Feb; 10(1):2778. PubMed ID: 32066753 [TBL] [Abstract][Full Text] [Related]
13. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps. Ilie M; Nunes M; Blot L; Hofman V; Long-Mira E; Butori C; Selva E; Merino-Trigo A; Vénissac N; Mouroux J; Vrignaud P; Hofman P Cancer Med; 2015 Feb; 4(2):201-11. PubMed ID: 25470237 [TBL] [Abstract][Full Text] [Related]
14. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868 [TBL] [Abstract][Full Text] [Related]
15. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009 [TBL] [Abstract][Full Text] [Related]
16. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. Bissig-Choisat B; Kettlun-Leyton C; Legras XD; Zorman B; Barzi M; Chen LL; Amin MD; Huang YH; Pautler RG; Hampton OA; Prakash MM; Yang D; Borowiak M; Muzny D; Doddapaneni HV; Hu J; Shi Y; Gaber MW; Hicks MJ; Thompson PA; Lu Y; Mills GB; Finegold M; Goss JA; Parsons DW; Vasudevan SA; Sumazin P; López-Terrada D; Bissig KD J Hepatol; 2016 Aug; 65(2):325-33. PubMed ID: 27117591 [TBL] [Abstract][Full Text] [Related]
17. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma. Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related]
19. Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer? Sereti E; Karagianellou T; Kotsoni I; Magouliotis D; Kamposioras K; Ulukaya E; Sakellaridis N; Zacharoulis D; Dimas K J Proteomics; 2018 Sep; 188():107-118. PubMed ID: 29398619 [TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors. Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]